Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOLFIRI Fort + Bevacizumab in mCRC
NCT00628810Phase 2Completed
- Sponsor
- Fédération Francophone de Cancérologie Digestive
- Start
- Jan 2007
- Primary completion
- Jan 2008
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in metastatic colorectal cancer (mCRC), sponsored by Fédération Francophone de Cancérologie Digestive. Started Jan 2007; status: completed.
02
Drugs
bevacizumab
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT00628810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00628810.